FDA data on chemical abortions scrutinized in new study

The FDA’s data on chemical abortions is encountering fresh scrutiny from authors alleging that significant discrepancies have occurred in previous figures.The FDA’s data on chemical abortions is encountering fresh scrutiny from authors alleging that significant discrepancies have occurred in previous figures.

Related articles

You may also be interested in

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.